These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 15204011
1. Xaliproden in amyotrophic lateral sclerosis: early clinical trials. Lacomblez L, Bensimon G, Douillet P, Doppler V, Salachas F, Meininger V. Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):99-106. PubMed ID: 15204011 [Abstract] [Full Text] [Related]
5. [The advance in the research and therapeutic trials of amyotrophic lateral sclerosis]. Moriwaka F, Tashiro K. Rinsho Shinkeigaku; 2000 Dec; 40(12):1258-60. PubMed ID: 11464472 [Abstract] [Full Text] [Related]
7. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival. Vender RL, Mauger D, Walsh S, Alam S, Simmons Z. Amyotroph Lateral Scler; 2007 Feb; 8(1):36-41. PubMed ID: 17364434 [Abstract] [Full Text] [Related]
8. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis. Liu XX, Zhang J, Zheng JY, Zhang S, Xu YS, Kang DX, Fan DS. Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412 [Abstract] [Full Text] [Related]
10. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Neurology; 2009 Jun 02; 72(22):1948-52. PubMed ID: 19487653 [Abstract] [Full Text] [Related]
11. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis. Pinto S, de Carvalho M. Muscle Nerve; 2008 Oct 02; 38(4):1312-7. PubMed ID: 18785186 [Abstract] [Full Text] [Related]
12. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Huang H, Chen L, Xi H, Wang H, Zhang J, Zhang F, Liu Y. Clin Transplant; 2008 Oct 02; 22(6):710-8. PubMed ID: 18673377 [Abstract] [Full Text] [Related]
18. SR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases. Porzner M, Müller T, Seufferlein T. Expert Opin Investig Drugs; 2009 Nov 02; 18(11):1765-72. PubMed ID: 19814656 [Abstract] [Full Text] [Related]
19. Defining survival as an outcome measure in amyotrophic lateral sclerosis. Gordon PH, Corcia P, Lacomblez L, Pochigaeva K, Abitbol JL, Cudkowicz M, Leigh PN, Meininger V. Arch Neurol; 2009 Jun 02; 66(6):758-61. PubMed ID: 19506136 [Abstract] [Full Text] [Related]
20. A clinical pilot study: high frequency chest wall oscillation airway clearance in patients with amyotrophic lateral sclerosis. Chaisson KM, Walsh S, Simmons Z, Vender RL. Amyotroph Lateral Scler; 2006 Jun 02; 7(2):107-11. PubMed ID: 16753975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]